LACTOBACILLUS RHAMNOSUS AND BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS FOR USE IN PREVENTION OR TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS

USPTO Patent Application US 2017/0258856 A1
Application Date: Sep. 14th, 2017

ABSTRACT

The present invention relates to a composition comprising Lactobacillus rhamnosus, preferably strain ATCC53103, and Bifidobacterium animalis subsp. lactis, preferably strain DSM 15954, for use in reducing the duration and/or severity...
Assignee(s):
Application Number:
15/472,754
International Classification:
A61K 35/745 (20060101); A61K 35/747 (20060101); A61K 35/742 (20060101)
No Pictures Available

CLAIMS

What is claimed is:

1.-13. (canceled)

DESCRIPTION

FIELD OF THE INVENTION

The present invention relates to a composition comprising Lactobacillus rhamnosus, such as the strain deposited as ATCC 53103, and Bifidobacterium animalis subsp. lactis, such as the strain deposited as DSM 15954, for use in reducing the duration and severity of upper respiratory tract infection (URI), such as the common cold,...
Back to Top